People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alphyn Biologics, Inc. | — | Biotechnology | Series A | $9.3M | $30.8M | 2023 |
| Medella Springs, LLC | — | Other Health Care | Pre-Seed | $650K | $10.7M | 2021 |
Roger Griggs at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Roger Griggs on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cameron Durrant | 1 | 5 |
| Tony Shipley | 1 | 3 |
| Jeffrey Kossak | 1 | 1 |
| Gary Pekoe | 1 | 1 |
| Adel Mikhail | 1 | 1 |
| Neal Koller | 1 | 1 |
| Kelly Selby | 1 | 1 |
| Bruce McAnally | 1 | 1 |
| Michael Ewers | 1 | 1 |
| Steven Pentelnik | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.